DK0759775T3 - Flydende IFN-beta-formuleringer - Google Patents

Flydende IFN-beta-formuleringer

Info

Publication number
DK0759775T3
DK0759775T3 DK95921749T DK95921749T DK0759775T3 DK 0759775 T3 DK0759775 T3 DK 0759775T3 DK 95921749 T DK95921749 T DK 95921749T DK 95921749 T DK95921749 T DK 95921749T DK 0759775 T3 DK0759775 T3 DK 0759775T3
Authority
DK
Denmark
Prior art keywords
formulations
ifn beta
beta formulations
liquid
interferon
Prior art date
Application number
DK95921749T
Other languages
Danish (da)
English (en)
Inventor
Fabrizio Samaritani
Patrizia Natale
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK0759775T3 publication Critical patent/DK0759775T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95921749T 1994-05-16 1995-05-15 Flydende IFN-beta-formuleringer DK0759775T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM940300A IT1272252B (it) 1994-05-16 1994-05-16 Formulazioni liquide di interferone beta
PCT/EP1995/001825 WO1995031213A1 (fr) 1994-05-16 1995-05-15 Formulations liquides d'interferon beta

Publications (1)

Publication Number Publication Date
DK0759775T3 true DK0759775T3 (da) 2000-11-13

Family

ID=11402534

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95921749T DK0759775T3 (da) 1994-05-16 1995-05-15 Flydende IFN-beta-formuleringer

Country Status (13)

Country Link
US (2) US6852314B1 (fr)
EP (1) EP0759775B1 (fr)
JP (1) JP3701675B2 (fr)
AT (1) ATE194917T1 (fr)
AU (1) AU704827B2 (fr)
CA (1) CA2190465A1 (fr)
DE (1) DE69518152T2 (fr)
DK (1) DK0759775T3 (fr)
ES (1) ES2148526T3 (fr)
GR (1) GR3034309T3 (fr)
IT (1) IT1272252B (fr)
PT (1) PT759775E (fr)
WO (1) WO1995031213A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952300A (en) * 1996-04-19 1999-09-14 Merck & Co., Inc. Antifungal compositions
SK284989B6 (sk) * 1996-12-24 2006-04-06 Biogen, Inc. Kvapalná kompozícia obsahujúca interferón a spôsob stabilizácie interferónu
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
DK1017413T4 (da) 1997-09-23 2008-03-25 Rentschler Biotech Gmbh Flydende formulering af interferon-beta
KR19990075253A (ko) * 1998-03-18 1999-10-15 성재갑 약학적으로 안정한 인터페론 제
AU3473999A (en) * 1998-04-03 1999-10-25 Chiron Corporation Injectable igf-formulations containing succinate as buffering agent
HU228583B1 (en) 2000-11-07 2013-04-29 Novartis Vaccines & Diagnostic Stabilized interferon compositions
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano
TWI272948B (en) * 2003-05-01 2007-02-11 Ares Trading Sa HSA-free stabilized interferon liquid formulations
EA012205B1 (ru) * 2004-05-17 2009-08-28 Арес Трейдинг С.А. Гидрогелевые препараты интерферона
BRPI0510526A (pt) * 2004-06-01 2007-10-30 Ares Trading Sa formulações lìquidas estabilizadas de interferon
US7913435B1 (en) * 2005-09-28 2011-03-29 Hummel Iii John F Vehicle display bracket system
SI2234645T1 (sl) * 2007-12-20 2012-07-31 Merck Serono Sa Formulacije peg interferon beta
US20120269770A1 (en) * 2010-11-22 2012-10-25 Mark Brader Stable Preserved Compositions of Interferon-Beta
WO2017170626A1 (fr) * 2016-03-30 2017-10-05 千寿製薬株式会社 Agent liquide aqueux

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
EP0080879B1 (fr) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Composition pharmaceutique contenant de l'interféron stabilisé
AU1234383A (en) 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
US5643566A (en) * 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
CA1294215C (fr) 1986-10-27 1992-01-14 Ze'ev Shaked Compositions pharmaceutiques d'interferon beta recombinant et methodes de formulation
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
IL88233A (en) 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon

Also Published As

Publication number Publication date
DE69518152T2 (de) 2000-12-14
PT759775E (pt) 2000-11-30
US6852314B1 (en) 2005-02-08
US20040265270A1 (en) 2004-12-30
WO1995031213A1 (fr) 1995-11-23
EP0759775A1 (fr) 1997-03-05
AU2670495A (en) 1995-12-05
IT1272252B (it) 1997-06-16
JPH10500125A (ja) 1998-01-06
CA2190465A1 (fr) 1995-11-23
ITRM940300A1 (it) 1995-11-16
ES2148526T3 (es) 2000-10-16
US7407651B2 (en) 2008-08-05
EP0759775B1 (fr) 2000-07-26
JP3701675B2 (ja) 2005-10-05
GR3034309T3 (en) 2000-12-29
AU704827B2 (en) 1999-05-06
ATE194917T1 (de) 2000-08-15
ITRM940300A0 (it) 1994-05-16
DE69518152D1 (de) 2000-08-31

Similar Documents

Publication Publication Date Title
DK0759775T3 (da) Flydende IFN-beta-formuleringer
IT8520242A0 (it) Polipeptide umano fisiologicamente attivo.
IT8619338A0 (it) Peptide sintetico ad attivita'interleukina 1 umana.
ATE77556T1 (de) Stabilisierte humanprotein-praeparate.
NO941186D0 (no) Hormonanaloger med multiple CTP-forlengelser
ITTO920080A1 (it) Catalizzatore di idrogenazione, procedimento per la sua preparazione ed impiego, particolarmente per l'idrogenazione e/o idrogenolisi di carboidrati e polioli.
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
DE69514342D1 (de) Modifizierte polypeptide mit erhoehter biologischer aktivitaet
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
IT1291366B1 (it) Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale
FR2691465B1 (fr) Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
IT9019754A0 (it) Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
ES2177625T3 (es) Citoquina cc-1 humana circulante.
ATE189262T1 (de) Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen
IT8819791A0 (it) Peptidi ad attivita' farmaceutica.
ZA935441B (en) Biologically active porcine somatotropin polypeptides and methods of using the same.
HUT63575A (en) Stabilized pharmaceutical composition comprising the reduced form of non-glycosylated, recombinant human interleukin-2
IT1230755B (it) Sistema di articolazione per mobili e suo procedimento di montaggio.
Hee Pancreatic secretions in the growing pig
IT8819790A0 (it) Peptidi ad attivita' farmaceutica.
IT8420759A0 (it) Composizione ad attivita'farmaceutica perfezionata e sua utilizzazione per usi veterinari.
Glimm Molecular and cellular bases of the role of growth hormone in bovine mammary biology
NO912072L (no) Rekombinante proteiner med adipsin- og komplement-d-aktiviteter.
ITMI921950A0 (it) Composizioni farmaceutiche ad attivita' epato-trofica ed anti-aging
IT1227892B (it) Composizioni farmaceutiche ad attivita' antidepressiva e ansiolitica